跳至主要内容
临床试验/CTRI/2011/09/001989
CTRI/2011/09/001989尚未招募3 期

A Clinical trial to study the efficacy, safety and tolerability of Carvedilol Phosphate ER 10 mg + Amlodpine 5 mg Capsule Vs Amlodipine 5 mg + Metoprolol 50 mg Tablet in Patients with Mild to severe Heart Failure.

Ajanta Pharma Ltd0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Male or Female patients with age between 18 & 60 years
  • 2.Patients with clinically diagnosis of Mild to severe Heart Failure
  • 3.Written informed consent to participate to the trial.

排除标准

  • 1.Males or females, less than 18 or more than 60 years of age
  • 2.History of hypersensitivity to the study drug or similar class of drug.
  • 3.Significant history or presence of gastrointestinal, liver or kidney disease, or any other conditions known to interfere with the absorption, distribution, metabolism or excretion of common medications.
  • 4.Patients with serum creatinine greater than 2.5 mg/dl.
  • 5.History of drug dependency, alcohol abuse, or serious neurological or psychological disease.
  • 6.Participation in a clinical trial with an investigation drug within 30 days proceeding day one of this study.
  • 7.Use of enzyme-modifying drugs within 30 days prior to day 1 of this study.
  • 8.Any condition that, in the opinion of the investigator, does not justify the patient?s inclusion in the study.

研究者

相似试验